Related Experiment Video
Updated: Apr 21, 2026
In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Identification of Mediterranean mutation in Egyptian favism patients
H G Osman1, F M Zahran, A M A El-Sokkary
1Biochemistry Division, Chemistry Department, Faculty of Science, Mansoura University, Mansoura, Egypt. aelsokkary@mans.edu.eg.
Objectives:
Identify and screen the G6PD Mediterranean mutation in favism patients by applying a Amplification Refractory Mutation System Polymerase Chain Reaction (ARMS-PCR).
Patients And Methods:
A total of 114 unrelated Egyptians patients were included in the present study; their ages ranged between (2-9) years with male to female ratio 4.5:1. G6PD activity was determined qualitatively from red cell hemolysate during attack. The G6PD Mediterranean mutation in patients has been identified by ARMS-PCR.
Results:
G6PD deficiency was detected in 87.7%, (n=100). The frequency of G6PD Mediterranean mutation was (94.7%), (n=108). The association between G6PD deficiency and Mediterranean mutation was a highly significant.
Conclusions:
Glucose-6-phosphate dehydrogenase Mediterranean mutation is one of the most common mutations causing G6PD deficiency among Egyptian children with favism.
Related Concept Videos
01:40Overview of Metabolism
Plant Metabolism
Sunlight, the primary source of energy in plants, is first absorbed by the chlorophyll pigments present in their leaves. Plants then use this energy to carry out photosynthesis, where water is oxidized into oxygen and carbon dioxide...
01:29Pharmacogenomics: Identification of New Drug Targets
01:20Inborn Errors of Metabolism
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
01:16Drug toxicity: Idiosyncratic Reactions